Sexual Functioning in Women Using Levonorgestrel‐Releasing Intrauterine Systems as Compared to Copper Intrauterine Devices

• Published in: Journal of sexual medicine 2012-04, Vol.9 (4), p.1065-1073
• Main Authors: Enzlin, Paul, Weyers, Steven, Janssens, Dirk, Poppe, Willy, Eelen, Christa, Pazmany, Els, Elaut, Els, Amy, Jean‐Jacques
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Arousal - drug effects; Cross-Sectional Studies; Cu-IUD; Female; Health Surveys; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel - administration & dosage; Libido - drug effects; LNG-IUS; Middle Aged; Nonpermanent Contraception; Orgasm - drug effects; Partner Relation; Psychology; Reversible; Sexual Behavior - drug effects; Sexual Dysfunction; Sexual Dysfunction, Physiological - diagnosis; Sexual Dysfunction, Physiological - epidemiology; Sexual Dysfunctions, Psychological - diagnosis; Sexual Dysfunctions, Psychological - epidemiology; Statistics as Topic; Surveys and Questionnaires; Young Adult
• ISSN: 1743-6095; 1743-6109
• DOI: 10.1111/j.1743-6109.2011.02266.x

There has been little research published on the impact of intrauterine contraceptive (IUC) methods on sexual functioning. This study aimed: (i) to assess different aspects of sexual functioning, including the prevalence of sexual dysfunction in women using a levonorgestrel intrauterine system (LNG‐IUS); (ii) to compare this prevalence with that among copper‐releasing intrauterine device (Cu‐IUD) users; and (iii) to identify the relationship between psychological variables and sexual functioning in women using one of the aforementioned IUCs. In a multicenter cross‐sectional study, 845 women with an IUC were invited to fill out a questionnaire. The latter was returned by 402 (48%) of them: 353 women were LNG‐IUS users (88%) and 49 were Cu‐IUD users (12%). The questions asked pertained to depression, well‐being, marital relation quality, and sexual functioning. Sexual functioning was measured with the Short Sexual Functioning Scale. One‐third of LNG‐IUS users (33%) reported a sexual dysfunction. Of those, 20% reported an increased sexual desire, 25% a decreased sexual desire, 5% arousal problems, and 8% orgasm problems. Women using a LNG‐IUS did not differ significantly in distribution, type, or prevalence (32.9% vs. 36.7%) of sexual dysfunction, nor in depressive symptoms (Beck Depression Inventory score; 4.7 vs. 3.9; P = 0.33), general well‐being (WHO‐5 well‐being scale score; 16.8 vs. 17.7; P = 0.170), or partner relationship quality (Dyadic Adjustment Scale score; 107 vs. 108; P = 0.74) compared to Cu‐IUD users. Overall, the perceived influence of IUCs on sexual functioning was in the lower range and did not differentiate LNG‐IUS greatly from Cu‐IUD‐users. Women using a LNG‐IUS do not differ from those wearing a Cu‐IUD with regard to psychological and sexual functioning. The perceived impact of IUD use on sexuality should not be overestimated. Enzlin P, Weyers S, Janssens D, Poppe W, Eelen C, Pazmany E, Elaut E, and Amy J‐J. Sexual functioning in women using levonorgestrel‐releasing intrauterine systems as compared to copper intrauterine devices. J Sex Med 12;9:1065–1073.